Literature DB >> 11846203

Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.

D Grenier1, P Plamondon, T Sorsa, H M Lee, T McNamara, N S Ramamurthy, L M Golub, O Teronen, D Mayrand.   

Abstract

BACKGROUND: Tetracyclines, particularly doxycycline (Doxy), and their non-antimicrobial chemically-modified derivatives (CMTs) inhibit the activities of human matrix metalloproteinases (MMPs), and reduce the severity and progression of periodontal disease in animal models and humans. In this study, the effects of Doxy and CMT-1, -3, and -5 on proteolytic, serpinolytic, and progelatinase-B activation activities of potent periodontopathogens were studied.
METHODS: The effect of Doxy and CMTs (0.5 to 50 microM) on proteolytic activities were investigated by incubating bacteria with chromogenic substrates or human serum albumin. A collagenolytic fraction of Porphyromonas gingivalis was used to evaluate the effect of these substances on collagenolytic (type I collagen) and serpinolytic (alpha1-proteinase inhibitor) activities. Lastly, the effect of Doxy on progelatinase-B (pro-MMP-9) activation by purified proteinases from P. gingivalis and Treponema denticola was investigated by SDS-PAGE/Western immunoblotting.
RESULTS: Doxy and CMTs, except CMT-5 which lacks the structural elements required for cation chelation, inhibited Arg- and Lys-gingipain activities as well as collagenolytic activity of P. gingivalis. Doxy and CMTs did not markedly affect the chymotrypsin-like activity of T. denticola but inhibited its trypsin-like activity. In addition, degradation of human serum albumin by cells of P. gingivalis and T. denticola was strongly inhibited by Doxy and CMT-1. Doxy and CMT-1 also inhibited the inactivation of alpha1-proteinase inhibitor (serpinolytic activity) by a collagenolytic fraction of P. gingivalis. Lastly, Doxy prevented the latent to active conversion of human neutrophil progelatinase-B (pro-MMP-9) by Arg-gingipains A/B of P. gingivalis but not by the chymotrypsin-like proteinase of T. denticola.
CONCLUSIONS: Data from this study suggest that Doxy and CMTs have the potential to inhibit the periodontopathogenic bacterial proteinases, which contribute to tissue destruction cascades during periodontitis directly and indirectly by triggering the host response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846203     DOI: 10.1902/jop.2002.73.1.79

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  14 in total

Review 1.  Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.

Authors:  Michael O Griffin; Eduardo Fricovsky; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

2.  Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition.

Authors:  Michael O Griffin; Miki Jinno; Lindsey A Miles; Francisco J Villarreal
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.

Authors:  Aurigena Antunes Araújo; Graziene Lopes de Souza; Tatiana Oliveira Souza; Gerly Anne de Castro Brito; Karoline Sabóia Aragão; Caroline Addison Xavier de Medeiros; Yriu Lourenço; Maria do Socorro Costa Feitosa Alves; Raimundo Fernandes de Araújo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-19       Impact factor: 3.000

Review 4.  Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.

Authors:  Michael O Griffin; Guillermo Ceballos; Francisco J Villarreal
Journal:  Pharmacol Res       Date:  2010-10-14       Impact factor: 7.658

5.  Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis.

Authors:  Rupali Agnihotri; Sumit Gaur
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

6.  Latency, thermal stability, and identification of an inhibitory compound of mirolysin, a secretory protease of the human periodontopathogen Tannerella forsythia.

Authors:  Krzysztof M Zak; Mark J Bostock; Irena Waligorska; Ida B Thøgersen; Jan J Enghild; Grzegorz M Popowicz; Przemyslaw Grudnik; Jan Potempa; Miroslaw Ksiazek
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-Pro.

Authors:  Peter Durand Skottrup; Grete Sørensen; Miroslaw Ksiazek; Jan Potempa; Erik Riise
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

8.  Host modulation by therapeutic agents.

Authors:  Sugumari Elavarasu; Santhosh Sekar; Thamaraiselvan Murugan
Journal:  J Pharm Bioallied Sci       Date:  2012-08

9.  Biotic acts of antibiotics.

Authors:  Rustam I Aminov
Journal:  Front Microbiol       Date:  2013-08-19       Impact factor: 5.640

10.  Pleiotropy of chemically modified tetracycline in periodontitis.

Authors:  Ashish Agarwal
Journal:  J Pharm Bioallied Sci       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.